|
"yen cj"的相關文件
顯示項目 76-99 / 99 (共4頁)
<< < 1 2 3 4
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2013-02-01 |
Allergies and risk of head and neck cancer: An original study plus meta-analysis
|
Hsiao, JR;Ou, CY;Lo, HI;Huang, CC;Lee, WT;Huang, JS;Chen, KC;Wong, TY;Tsai, ST;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, JY;Chang, KY;Lin, CL;Wang, FT;Wang, YH;Weng, YL;Yang, HC;Chang, JS |
| 國家衛生研究院 |
2013-02 |
Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients
|
Hsieh, YH;Su, IJ;Yen, CJ;Tsai, TF;Tsai, HW;Tsai, HN;Huang, YJ;Chen, YY;Ai, YL;Kao, LY;Hsieh, WC;Wu, HC;Huang, W |
| 臺北醫學大學 |
2013 |
Dissecting the EGFR-P13K-AKT pathway in oral cancer highlights the roles of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsia, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;chang, JY |
| 國家衛生研究院 |
2012-07-27 |
Hepatitis B virus X protein upregulates mTOR signaling through IKKBeta to increase cell proliferation and VEGF production in hepatocellular carcinoma
|
Yen, CJ;Lin, YJ;Yen, CS;Tsai, HW;Tsai, TF;Chang, KY;Huang, WC;Lin, PW;Chiang, CW;Chang, TT |
| 國家衛生研究院 |
2011-11-15 |
Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo
|
Chang, KY;Tsai, SY;Wu, CM;Yen, CJ;Chuang, BF;Chang, JY |
| 國家衛生研究院 |
2011-09-23 |
A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou
|
Chang, KY;Yen, CJ;Hsieh, CY;Tsou, HH;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY |
| 國家衛生研究院 |
2011-09 |
Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers
|
Yeh, K;Shen, YC;Li, CP;Yen, CJ;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Cheng, AL |
| 國家衛生研究院 |
2011-07-01 |
A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery
|
Tsai, HW;Lin, YJ;Lin, PW;Wu, HC;Hsu, KH;Yen, CJ;Chan, SH;Huang, W;Su, IJ |
| 國家衛生研究院 |
2011-06-23 |
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells
|
Chen, YJ;Huang, WC;Wei, YL;Hsu, SC;Yuan, P;Lin, HY;Wistuba, I;Lee, JJ;Yen, CJ;Su, WC;Chang, KY;Chang, WC;Chou, TC;Chou, CK;Tsai, CH;Hung, MC |
| 國家衛生研究院 |
2010-10 |
A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
|
Li, CP;Chen, JS;Chen, LT;Yen, CJ;Lee, KD;Su, WP;Lin, PC;Lu, CH;Tsai, HJ;Chao, Y |
| 國家衛生研究院 |
2010-08 |
Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults
|
Kuo, HK;Chen, CY;Liu, HM;Yen, CJ;Chang, KJ;Chang, CC;Yu, YH;Lin, LY;Hwang, JJ |
| 國家衛生研究院 |
2010-02-09 |
ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway
|
Kuo, HP;Lee, DF;Chen, CT;Liu, M;Chou, CK;Lee, HJ;Du, Y;Xie, XM;Wei, YK;Xia, WY;Zhang, WH;Yang, JY;Yen, CJ;Huang, TH;Tan, MJ;Xing, G;Zhao, YM;Lin, CH;Tsai, SF;Fidler, IJ;Hung, MC |
| 國家衛生研究院 |
2009-05 |
Hepatitis B virus-X protein upregulates TSC1/m-TOR pathway and enhance angiogenesis in hepatitis B associated hepatocellular carcinoma
|
Yen, CJ;Tsai, HW;Chang, KY;Cheng, CC;Lin, PW;Chang, TT;Chiang, CW |
| 國立臺灣大學 |
2009-03 |
Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults
|
Kuo, HK; Chen; CY; Liu, HM; Yen, CJ; Chang, KJ; Chang, CC; Yu, YH; Lin, LY; Hwang, JJ |
| 國立臺灣大學 |
2007-11 |
Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future Strategies.
|
Ni, YH; Huang, LM; Chang, MH; Yen, CJ; Lu, CY; You, SL; Kao, JH; Lin, YC; Chen, HL; Hsu, HY; Chen, DS. |
| 國家衛生研究院 |
2007-02-26 |
The role of the VEGF-C/VEGFR-3 axis in cancer progression
|
Su, JL; Yen, CJ; Chen, PS; Chuang, SE; Hong, CC; Kuo, IH; Chen, HY; Hung, MC; Kuo, ML |
| 國立臺灣大學 |
2007-02 |
The role of the VEGF-C/VEGFR-3 axis in cancer progression.
|
Su JL; Yen CJ; Chen PS; Chuang SE; Hong CC; Kuo IH; Chen HY; Hung MC; Kuo ML |
| 國立臺灣大學 |
2007 |
The Association between Abnormal Liver Function and Risk Factors of Metabolic Syndrome among Freshmen
|
Tsai, PY; Yen, CJ; Li, YC; Chiu, TY; Chen, CY; Jan, CF |
| 國立臺灣大學 |
2007 |
The Seroprevalence of Hepatitis B Viral Markers among Freshmen – 20 Years after Mass Hepatitis B Vaccination Program in Taiwan
|
Chang, HC; Yen, CJ; Li, YC; Chiu, TY; Jan, CF |
| 國立臺灣大學 |
2006-08 |
Exploring how peak leg power and usual gait speed are linked to late-life disability: data from the National Health and Nutrition Examination Survey (NHANES), 1999-2002
|
Kuo, HK; Leveille, SG; Yen, CJ; Chai, HM; Chang, CH; Yeh, YC; Yu, YH; Bean, JF |
| 國家衛生研究院 |
2005-10 |
Levels of homocysteine are inversely associated with cardiovascular fitness in women, but not in men: data from the National Health and Nutrition Examination Survey 1999-2002
|
Kuo, HK; Yen, CJ; Bean, JF |
| 國家衛生研究院 |
2005-06 |
Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis
|
Kuo, HK; Yen, CJ; Chang, CH; Kuo, CK; Chen, JH; Sorond, F |
| 國家衛生研究院 |
2005-04 |
The role of C-reactive protein (CRP) in stroke: A meta-analysis
|
Kuo, HK;Yen, CJ;Chang, CH;Kuo, C;Yeh, YC;Chen, JH;Sorond, F |
| 國家衛生研究院 |
2005-04 |
Gait speed, lower body strength, and levels of homocysteine in the elderly
|
Kuo, HK;Yen, CJ |
顯示項目 76-99 / 99 (共4頁)
<< < 1 2 3 4
每頁顯示[10|25|50]項目
|
